SCHEMBL12818272

SCHEMBL12818272

Cc1nc2cc(S(=O)(=O)N3CCSc4ccc(-c5csc(C#N)c5)cc43)ccc2o1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 1/20 0.35
▸ CPT2 P23786 2/20 0.34
▸ CPT1A P50416 2/20 0.34
▸ CPT1B Q92523 2/20 0.34
▸ GAA P10253 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ RORC P51449 4/20 0.32
▸ HSPD1 P10809 1/20 0.32
▸ PTPN2 P17706 1/20 0.32
▸ PTPN1 P18031 1/20 0.32
▸ PTPN5 P54829 1/20 0.32
▸ HSPE1 P61604 1/20 0.32
▸ NR1I2 O75469 1/20 0.32
▸ NR1H2 P55055 1/20 0.32
▸ NR1H3 Q13133 1/20 0.32
▸ PGR P06401 2/20 0.31
▸ NR3C1 P04150 1/20 0.31
▸ NR3C2 P08235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12817890 0.89 HSPD1 (0.40) GCKCPT2CPT1ACPT1BGAA
SCHEMBL12819156 0.87 PGR (0.39) GCKCPT2CPT1ACPT1BGAA
SCHEMBL12817711 0.85 GCK (0.36) GCKCPT2CPT1ACPT1BGAA
SCHEMBL12817769 0.85 CYP2C9 (0.38) GCKCPT1ACPT1BGAAL3MBTL1
SCHEMBL12817702 0.82 PKM (0.41) CPT2CPT1ACPT1BALDH1A1MAPT
SCHEMBL12818327 0.82 CYP11B1 (0.38) CPT2CPT1ACPT1BCNR1CNR2
SCHEMBL12817644 0.80 PGR (0.37) GCKCPT2CPT1ACPT1BCNR1
SCHEMBL12818293 0.80 CPT2 (0.35) GCKCPT2CPT1ACPT1BGAA
SCHEMBL12817768 0.80 BRD4 (0.40) CPT2CPT1ACPT1BCNR1CNR2
SCHEMBL1818508 0.79 CNR1 (0.39) CPT2CPT1ACPT1BCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback